NF-кB与子宫内膜异位症关系的研究进展
被引量:1
摘要
NF-кB是一类具有多向调节作用的转录调控因子家族,与子宫内膜异位症的发生、发展相关。现对NF-κB的结构及调节,及其与子宫内膜异位症关系的研究进展,旨在为子宫内膜异位症的诊治提供新的依据。
出处
《现代妇产科进展》
CSCD
北大核心
2009年第4期306-308,共3页
Progress in Obstetrics and Gynecology
参考文献20
-
1Witz CA, Bedaiwy MA, Falcone T, et al. Interleukin-6 : another Piece of the endometriosis -cytokine puzzle[ J]. Fertil Steril,2000,73:212-214
-
2Yamauchi N, Harada T, Taniguchi F, et al. Tumor necrosis factor-alpha induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-kappaB and mitogen activated protein kinase pathways [ J ]. Fertil Steril,2004,82 : 1023-1028
-
3Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity [ J ]. Science, 1966,153:80-82
-
4Akoum A, Kats R, Metz CN.Macrophage migration inhibitory factor is markedly expressed in active and early-stage endometriotic lesions [ J ]. Clin Endocrinol Metab, 2002, 87:883-889
-
5Morin M, Bellehumeur C, Therriault M J, et ah Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis[J]. Fertil Steril, 2005,83 : 865-872
-
6Veillat V, Lavoie CH, Metz CN, et al. Involvement of nuclear factor-kappaB in macrophage migration inhibitory factor gene transcription up-regulation induced by interleukin-1 beta in ectopic endometrial cells [ J ]. Fertil Steril, 2005 [ Epub ahead of print ]
-
7Donnez J, Smoes D, Gillerot S, et al. Vascular endothelial growth factor (VEGF) in endometriosis [ J ]. Hum Reprod, 1998,13 : 1686-1690
-
8王芳,何援利,罗敏,宗利丽,赵汝珠,刘木彪.子宫内膜异位症核转录因子和血管内皮生长因子表达与预后的关系[J].西北国防医学杂志,2007,28(2):116-119. 被引量:6
-
9Wabe T, Harada T,Terakawa N. Role of cytokines in endometriosis associated infertility [ J ]. Gynecol obstet Invest,2002,53 : 11-25
-
10Grund EM, Kagan D, Tran CA, et al. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells[ J]. Mol Pharmacol,2008,73 : 1394-1404
二级参考文献13
-
1Fuhrrnann U, Hess-Stumpp H, Cleve A, et al. Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist. J Med Chem, 2000,43:5010-5016.
-
2Zhao D, Lebovic DI, Taylor RN. Long-term progestin treatment inhibits RANTES ( regulated on activation, normal T cell expressed and secreted) gene expression in human endometrial stromal cells. J Clin Endocrinol Metab, 2002,87:2514-2519.
-
3Lebovic DI, Chao VA, Martini JF, et al. IL-lbeta induction of RANTES (regulated upon activation, normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on a nuclear factor-kappa B site in the proximal promoter. J Clin Endocrinol Metab,2001,86:4759-4764.
-
4Page M, Tuckerman EM, Li TC, et al. Expression of nuclear factor kappa B components in human endometrium. J Reprod Immunol,2002,54 : 1-13.
-
5Murphy AA, Zhou MH, Malkapuram S, et al. RU486-induced growth inhibition of human endometrial cells. Fertil Steril, 2000,74:1014-1019.
-
6Han S, SideU N. RU486-induced growth inhibition of human endometrial eeUs involves the nuclear factor-kappa B signaling pathway. J Clin Endoerlnol Metab, 2003,88:713-719.
-
7Sakamoto Y, Harada T, Horie S, et al. Tumor necrosis factor-alphainduced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-kappa B activation :gonadotropin-releasing hormone agonist treatment reduced IL-8 expression. J Clin Endocrinol Metab, 2003,88:730-735.
-
8Dvorak HF,Brown LF,Detmar M,et al.Vascular permeability factor/vascular endothelial growth factor,microvascular hyperpermeability,and angiogenesis[ J ].Am J Pathol,1995,146(5):1029-1039.
-
9Mayo MW,Baldwin AS.The transcription factor NF-kappaB:control of onco -genesis and cancer therapy resistance[ J ].Biochim Biophys Acta,2000,1470:55-62.
-
10Kiriakidis S,Andreakos E,Monaco C,et al.VEGF expression in human macrophages is NF-kappaB-dependent:studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase[ J ].Cell Sci,2003,116 (4):665-674.
共引文献13
-
1郭立新,刘建燕.保守性手术联合米非司酮治疗中重度子宫内膜异位症的临床观察[J].实用医院临床杂志,2008,5(2):70-71.
-
2王远菊,张洪文,李晓东,赵素萍,孟凡珍,冯桂军.子宫内膜异位症术后米非司酮疗效与孕激素受体的关系初步研究[J].中国现代医学杂志,2005,15(21):3295-3298. 被引量:15
-
3丰靖卿,宋志英,李兆艾.米非司酮在妇产科的应用进展[J].山西医药杂志,2006,35(4):325-327. 被引量:1
-
4王福玲,赵兴波,李明江,李继俊.米非司酮对子宫内膜癌细胞系E-钙粘素和核因子kappa B表达的影响[J].现代妇产科进展,2008,17(8):609-612. 被引量:7
-
5丰靖卿,李兆艾.子宫内膜异位症药物治疗现状及研究进展[J].赣南医学院学报,2009,29(3):474-476. 被引量:9
-
6黄瑞连,欧定宏.米非司酮药理作用机制研究进展[J].临床合理用药杂志,2009,2(23):142-144. 被引量:22
-
7张云莎,章明放,李伟.RU486对子宫内膜增生症腺上皮中NF-κB/p65、p16和ki67蛋白表达水平的影响[J].生殖与避孕,2009,29(12):796-801. 被引量:1
-
8郝臻凤,杨纪实,姜郁,孔祥.NF-κB、MIF在子宫内膜异位症的表达及意义[J].现代妇产科进展,2012,21(2):120-123. 被引量:4
-
9张静,蒙秋,王海燕,黄守国.异位内膜侵袭与肿瘤转移相关基因表达的研究进展[J].医学综述,2013,19(8):1414-1416. 被引量:3
-
10王彦,郭维婵.血管生成在子宫内膜异位症形成中的研究进展[J].医学综述,2014,20(22):4111-4114. 被引量:8
同被引文献25
-
1林津,马炎辉,刘鹏博(编校).卵巢子宫内膜异位症相关因素分析[J].中国妇幼保健,2007,22(5):570-572. 被引量:9
-
2孙咏梅,金海红,徐应军,李桂荣.盆腔子宫内膜异位症相关因素分析[J].中国综合临床,2007,23(11):1035-1037. 被引量:2
-
3Rier SE. Environmental immune disruption: a comorbidity factor for reproduction [ J 1. Fertil Steril, 2008,89 ( Suppl 2 ) : 103-108.
-
4Claire Templeman, Sarah F. Marshall, Giske Ursin, et al. Adenomyosis and endometriosis in the California Teachers Study [J]. Fertility and Sterility, 2008, 90(2) : 415-424.
-
5V.L. Kodati, S. Govindan, S. Movva, et al. Role of shigella infection in endometriosis: A novel hypothesis [ J ]. Medical Hypotheses,2008, 70(2): 239-243.
-
6Susan A. Treloar, Tanya A. Bell, Christina M. Nagle, et al. Early menstrual characteristics associated with subsequent diagnosis of eudometriosis [ J ]. American Journal of Obstetrics and Gynecology, 2010, 202(6): 534 -534.
-
7Porpora, Mafia Grazia, Medda, et al. Endometriosis and Organochlofinated Environmental Pollutants: A Case-Control Study on Italian Women of Reproductive Age [ J ].Environmental Health Perspectives,2009,117 (7) : 1070-7075.
-
8Weuve, Jennifer, Hauser, et al. Association of Exposure to Phthalates with Endometriosis and Uterine Leiomyomata: Findings from NHANES, 1999-2004 [ J]. Environmental Health Perspectives, 2010, 118(6) : 825-832.
-
9Maureen A. Cooney, Germaine M. Buck Louis, Mary L. Hediger. Organoehlorine pesticides and endometriosis [ J ]. Reproductive Toxicology, 2010, 30 (3) : 365-369.
-
10杨鉴冰,陈梅,刘东平.子宫内膜异位症的中医病因病机及治疗探讨[J].四川中医,2008,26(2):21-22. 被引量:21
二级引证文献12
-
1柴华,王嘉梅.理气活血法治疗气滞血瘀型子宫内膜异位症痛经73例的临床效果[J].中国医药导报,2015,12(19):89-92. 被引量:17
-
2李霞,张俊,周春.术前复方莪术散治疗对子宫内膜异位症患者血清学指标及内膜组织中相关信号通路功能的影响[J].海南医学院学报,2015,21(11):1528-1531. 被引量:10
-
3袁江莎.子宫内膜异位症的研究及治疗进展[J].中外女性健康研究,2016,0(6):234-235. 被引量:2
-
4郑丽丽,李伟,黄荳,罗琳,罗晓红,李渊.丹参酮ⅡA对子宫内膜异位症模型大鼠的治疗作用[J].医药导报,2016,35(6):612-615. 被引量:5
-
5袁江莎.子宫内膜异位症的研究及治疗进展[J].中外女性健康研究,2016(10):165-165. 被引量:1
-
6张蔚苓,赵珊琼.滋肾凉血调周法治疗子宫内膜异位症合并不孕患者的疗效及对血清VEGF的影响[J].中华全科医学,2018,16(11):1897-1900. 被引量:5
-
7李秋敏,袁峰,王亚琴.血清维生素D水平对子宫内膜异位症的评估价值[J].中国医学前沿杂志(电子版),2019,11(3):128-131. 被引量:3
-
8王珍贞,徐莲薇,刘敛,赵莉,赵巍.李祥云治疗子宫内膜异位症经验[J].中医文献杂志,2019,37(4):45-48. 被引量:2
-
9孙雪琴,丛慧芳,张天婵.桂香温经止痛胶囊治疗寒凝血瘀型子宫内膜异位症痛经临床研究[J].中医药信息,2019,36(6):75-78. 被引量:13
-
10于洋,张天婵,李阳,丛慧芳.针灸疗法治疗子宫内膜异位症的临床研究进展[J].针灸临床杂志,2020,36(5):95-99. 被引量:7
-
1朱炜.子宫腺肌病组织中核转录因子-кBp65的表达及意义[J].深圳中西医结合杂志,2016,26(4):10-11. 被引量:1
-
2蒋莹,黄利红.米非司酮对子宫腺肌病患者在位和异位内膜组织中多向生长因子表达的影响[J].广东医学,2010,31(21):2808-2810. 被引量:7
-
3成佳景.双胞胎及多胞胎孕妇应注意什么[J].健康向导,2013,19(4):24-24. 被引量:1
-
4黄安理.B超对宫内妊娠组织残留的诊断分析[J].中国医药指南,2014,12(15):92-92. 被引量:5
-
5蒋宇.Menin蛋白抑制孕鼠胰腺β细胞生长并促进妊娠糖尿病的发生[J].中国病理生理杂志,2007,23(12):2418-2418. 被引量:1
-
6张莹,王自能,黄以萍,郭祖文,刘惠敏.育龄妇女输卵管上皮周期变化的扫描电镜研究[J].河南医科大学学报,1998,33(4):95-98. 被引量:1
-
7唐慧子,李菲菲,韩旭.PEA3转录因子在卵巢癌浸润和转移中的相关研究[J].医学综述,2014,20(18):3317-3319. 被引量:2
-
8温传华.子宫腺肌症的超声诊断[J].中国医药指南,2010,8(11):74-75.
-
9李伟.孕产期保健知识的传授[J].临床合理用药杂志,2015,8(2):160-160. 被引量:1
-
10翟青枝,陈必良.HOXA-10基因影响胚胎着床机制及调节因素[J].中国妇幼健康研究,2008,19(3):263-265. 被引量:4